Best Pharma & Healthcare Funds
Defensive-growth exposure to pharma, hospitals and diagnostics.
18
Funds
1
Strong Buys
Very High
Risk
18 fundsSorted by Smart Score ↓
⚖Want to compare funds? Tick the checkbox in the first column — pick up to 5 and they'll go head-to-head in one view.
| ⚖ VS | Fund | Score ↓ | Verdict | 1Y | 3Y | 5Y | Sharpe | Sortino | Std Dev | Alpha | Beta | VR★ | P/E | Expense | AUM | Age |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma And Healthcare HDFC | 81 | Strong Buy | 19.3% | — | — | 1.79 | 2.56 | 14.2 | 20.4 | 0.65 | — | 47.4 | 1.15% | ₹2.6k Cr | 2.8y | |
| SBI Healthcare Opportunities SBI | 77 | Buy | 14.8% | 24.7% | 17.4% | 1.27 | 2.02 | 14.9 | 4.9 | 0.82 | — | 53.5 | 1.03% | ₹5.0k Cr | 13.5y | |
| ICICI Pru Pharma Healthcare And Diagnostics PHD ICICI Pru | 66 | Buy | 7.3% | 25.6% | 16.5% | 1.25 | — | 16.9 | 5.4 | 0.92 | — | — | 1.31% | ₹6.6k Cr | 8.0y | |
| UTI Healthcare UTI | 63 | Buy | 12.7% | 26.4% | 15.4% | 1.23 | 2.12 | 16.7 | 5.0 | 0.91 | — | 41.6 | 1.31% | ₹1.3k Cr | 13.5y | |
| Mirae Asset Healthcare Mirae Asset | 63 | Buy | 13.3% | 24.6% | 15.5% | 1.17 | 1.83 | 16.9 | 3.6 | 0.95 | — | 44.4 | 0.62% | ₹3.3k Cr | 8.1y | |
| DSP Healthcare DSP | 62 | Buy | 10.1% | 23.0% | 16.1% | 1.12 | 1.82 | 15.6 | 3.7 | 0.81 | — | 33.0 | 0.65% | ₹3.5k Cr | 7.6y | |
| WhiteOak Capital Pharma And Heathcare WhiteOak | 62 | Buy | 17.6% | — | — | 1.16 | 1.63 | 14.6 | 15.5 | 0.68 | — | 48.2 | 1.28% | ₹741 Cr | 2.5y | |
| Kotak Healthcare Kotak | 56 | Hold | 18.9% | — | — | 1.08 | 1.52 | 14.6 | 13.3 | 0.68 | — | 47.3 | 1.04% | ₹678 Cr | 2.6y | |
| PGIM India Healthcare PGIM India | 51 | Hold | 16.2% | — | — | 0.38 | 0.51 | 13.4 | 8.0 | 0.66 | — | 51.6 | 0.86% | ₹103 Cr | 1.7y | |
| ABSL Pharma And Healthcare Aditya Birla Sun Life | 50 | Hold | 14.9% | 23.6% | 14.5% | 1.15 | 1.92 | 16.2 | 3.1 | 0.91 | — | 47.4 | 1.01% | ₹950 Cr | 7.0y | |
| Bajaj FInserv Healthcare Bajaj Finserv | 40 | Avoid | 12.8% | — | — | 0.11 | 0.15 | 13.6 | 2.5 | 0.68 | — | 52.0 | 0.92% | ₹354 Cr | 1.6y | |
| Baroda BNP Paribas Health And Wellness Baroda BNP Paribas | 37 | Avoid | 5.6% | — | — | 0.00 | 0.00 | 11.6 | 3.2 | 0.55 | — | 46.8 | 1.00% | ₹553 Cr | 1.1y | |
| Tata India Pharma & Healthcare Tata | 36 | Avoid | 8.2% | 22.5% | 14.8% | 1.05 | 1.72 | 17.2 | 0.6 | 0.97 | — | 42.8 | 0.94% | ₹1.5k Cr | 10.6y | |
| Nippon India Pharma Nippon India | 35 | Avoid | 7.5% | 20.8% | 13.3% | 1.08 | 1.59 | 15.8 | 2.0 | 0.88 | — | 38.7 | 1.02% | ₹9.0k Cr | 13.5y | |
| Quant Healthcare Quant | 27 | Avoid | 11.0% | — | — | 0.90 | 1.24 | 17.2 | 8.8 | 0.91 | — | 44.5 | 1.38% | ₹385 Cr | 3.0y | |
| Bandhan Healthcare Bandhan | 25 | Avoid | — | — | — | — | — | — | — | — | — | 41.8 | 1.26% | ₹291 Cr | 0.7y | |
| LIC MF Healthcare LIC | 24 | Avoid | 9.0% | 22.6% | 11.9% | 1.08 | 1.49 | 16.4 | 2.6 | 0.88 | — | 50.1 | 1.53% | ₹93 Cr | 7.4y | |
| ITI Pharma And Healthcare ITI | 21 | Avoid | 5.6% | 20.7% | — | 0.95 | 1.40 | 16.8 | 0.3 | 0.92 | — | 45.2 | 0.95% | ₹252 Cr | 4.7y |
Reading the ratios: ↑ higher is better — Returns, Sharpe, Sortino, Alpha · ↓ lower is better — Std Dev, P/E, Expense · Beta ≈1 moves with the market (<1 swings less). Hover any column header for details.